🌅 Today's Morning Call
|
S&P Futures
7,641.75
▲ +39.00 (+0.51%)
|
Nasdaq Futures
29,330.00
▲ +260.00 (+0.89%)
|
Dow Futures
52,395.00
▲ +216.00 (+0.41%)
|
|
10Y Treasury
4.94%
▲ +0.11%
|
US Dollar
99.17
▲ +0.02 (+0.02%)
|
Bitcoin
$76,914
▲ +$382 (+0.50%)
|
Data as of 8:09 AM ET
Good morning! Happy Friday, and welcome to the last trading session of the week. Futures are pointing green across the board, with tech leading the way and the Nasdaq up nearly 0.9% before the bell. Rising Treasury yields are the wildcard to keep an eye on. Here's your morning rundown.
👀 What to Watch Today
The big theme heading into the open is rates versus risk appetite. The 10-year Treasury yield jumped to 4.94%, up 11 basis points, while the 5-year climbed to 4.73%. Normally higher yields spook equities, yet futures are shrugging it off with the Nasdaq leading the charge. That tension is worth watching all session.On the corporate front, Exelixis (EXEL) is front and center after the FDA extended its review of the company's colorectal cancer drug combination by three months. Regulatory delays rarely play well with biotech investors, so watch for volatility in the name.
Also keep tabs on macro headlines. Reports say Mexico and Washington are racing toward a bilateral trade deal ahead of the U.S. midterms, a development that could ripple through industrials, autos, and materials as the day unfolds.
Your Phone Is Smarter Than Your Inbox
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🌏 Overnight Recap
European markets set the tone overnight with bank stocks in focus. Sources say Berlin is pushing Commerzbank (CRZBF, CRZBY) to keep its German identity through a domestic listing and protect jobs as UniCredit (UNCFF) circles a potential takeover. The tug-of-war between national interest and cross-border M&A is a story to track into the U.S. open.Bayer (BAYRY, BAYZF) is also in the spotlight. Its Monsanto unit heads to a Missouri state court Monday seeking approval of a 7.25 billion dollar Roundup settlement that could resolve tens of thousands of U.S. lawsuits. Investors will be positioning ahead of that hearing.
Meanwhile, the dollar index ticked up slightly to 99.17 and Bitcoin held firm at roughly 76,900, up 0.5%. Crypto's steadiness alongside rising yields suggests risk appetite is holding for now.
Sponsored Content
Why Trump's Advisors Are Discussing Reversing a 1971 Policy
On a Sunday night in 1971, Nixon ended the gold standard in 15 minutes. No vote. No warning. Gold went up twenty times over the next decade. The people who saw it coming moved first. Everyone else watched their savings erode for years.
Trump holds that same executive authority today. His advisors are openly saying a reversal is on the table. If it happens, it moves fast.
📊 Pre-Market Movers
Exelixis (EXEL) is the name to watch this morning after the FDA extended its review timeline by three months. Delays like these tend to pressure biotech shares in early trade, so expect some downside jitters as investors reprice the drug's path to approval.European financials are stirring after the Commerzbank (CRZBF, CRZBY) headlines. UniCredit (UNCFF) shares and the broader banking complex could see ripple effects as the market weighs whether a German listing complicates the takeover math.
Bayer (BAYRY, BAYZF) is another one to monitor as traders position ahead of Monday's Missouri court hearing on the Roundup settlement. Any legal clarity, or lack of it, could swing the ADRs.
🔍 Today's Watchlist
- Exelixis (EXEL): FDA extended its colorectal cancer drug review by three months, watch for biotech volatility.
- Bayer (BAYRY): Missouri court test of its 7.25 billion dollar Roundup settlement looms Monday.
- Commerzbank (CRZBF) and UniCredit (UNCFF): Berlin pushes for a domestic listing amid takeover talks.
- 10-Year Treasury yield at 4.94%, up 11 basis points, the macro pressure point to monitor.
- Mexico-U.S. trade deal progress ahead of midterms could move industrials and materials.
Sponsored Content
URGENT: The $100 Stock Behind Elon's Next Move
It isn't Tesla. It isn't SpaceX. The one stock Elon cannot execute his next move without trades for under $100 a share right now, and almost nobody is talking about it.
A small supplier that's quietly worked alongside him for over a decade holds the single piece his entire AI-in-orbit plan depends on. September 25th is the date that matters.
🎯 The Morning Playbook
The play today is to respect the tension between climbing yields and a risk-on futures tape. Tech is leading, but a 10-year at 4.94% means rate-sensitive corners of the market can turn quickly. Stay nimble.For stock-specific action, keep single-name catalysts in view: EXEL on the FDA delay, BAYRY ahead of Monday's court test, and the European bank saga with CRZBF and UNCFF. These are the stories with real movement behind them.
It's Friday, so watch for late-session positioning ahead of the weekend. Trade the headlines you can verify, not the ones you imagine. Have a great close to the week.
📰 Further Reading
Gold Is Soaring But Are You Getting Paid Monthly? (Ad)
While gold posts its strongest gains since 1979, income expert Tim Plaehn reveals a quiet $15 fund turning this historic surge into massive monthly income: up to $1,152 every month.
Discover here the gold income strategy that pays you.
$200 Trillion AI "Treasure Map" (Ad)
A Pentagon AI system just uncovered 184,000 hidden gold sites across America. It also found hidden copper, silver, and a whole host of other resources. The end result? An AI "treasure map" that could be worth as much as $200 TRILLION.
See how you can claim your stake of this treasure here.
A "Bloodbath" Is Coming (Ad)
Silicon Valley billionaires are hoarding guns, gold, and even military grade gas masks... or fleeing the country altogether. What do they know that you don't? This AI insider is stepping forward with this time-critical message: Move your money by September 30th, ahead of the dangerous next phase of...
Here's the one urgent move you need to make with your money immediately.